BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34779530)

  • 1. Targeting T cell metabolism for immunotherapy.
    Gao J; Liu Y; Wei J; Jiang L; Mao J; Chang CH; Wu D
    J Leukoc Biol; 2021 Dec; 110(6):1081-1090. PubMed ID: 34779530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy.
    Rivadeneira DB; Delgoffe GM
    Clin Cancer Res; 2018 Jun; 24(11):2473-2481. PubMed ID: 29386217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition.
    Houot R; Schultz LM; Marabelle A; Kohrt H
    Cancer Immunol Res; 2015 Oct; 3(10):1115-22. PubMed ID: 26438444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles of adoptive T cell therapy in cancer.
    Met Ö; Jensen KM; Chamberlain CA; Donia M; Svane IM
    Semin Immunopathol; 2019 Jan; 41(1):49-58. PubMed ID: 30187086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-resident memory-like T cells in tumor immunity: Clinical implications.
    Dhodapkar MV; Dhodapkar KM
    Semin Immunol; 2020 Jun; 49():101415. PubMed ID: 33011063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.
    Gao A; Liu X; Lin W; Wang J; Wang S; Si F; Huang L; Zhao Y; Sun Y; Peng G
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell immunometabolism against cancer.
    Jiang S; Yan W
    Cancer Lett; 2016 Nov; 382(2):255-258. PubMed ID: 27664755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Barriers to T Cell Function in Tumors.
    Sugiura A; Rathmell JC
    J Immunol; 2018 Jan; 200(2):400-407. PubMed ID: 29311381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Reprogramming of CD4
    Renaude E; Kroemer M; Borg C; Peixoto P; Hervouet E; Loyon R; Adotévi O
    Front Immunol; 2021; 12():669992. PubMed ID: 34262562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive T cell therapy for cancer in the clinic.
    June CH
    J Clin Invest; 2007 Jun; 117(6):1466-76. PubMed ID: 17549249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic reprograming of anti-tumor immunity.
    Sukumar M; Kishton RJ; Restifo NP
    Curr Opin Immunol; 2017 Jun; 46():14-22. PubMed ID: 28412583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies.
    Dong Y; Wan Z; Gao X; Yang G; Liu L
    Front Immunol; 2021; 12():609762. PubMed ID: 33968014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive T cell therapy: Boosting the immune system to fight cancer.
    Leon E; Ranganathan R; Savoldo B
    Semin Immunol; 2020 Jun; 49():101437. PubMed ID: 33262066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.
    Ikeda H
    Int Immunol; 2016 Jul; 28(7):349-53. PubMed ID: 27127191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD137 monoclonal antibodies and adoptive T cell therapy: a perfect marriage?
    Weigelin B; Bolaños E; Rodriguez-Ruiz ME; Martinez-Forero I; Friedl P; Melero I
    Cancer Immunol Immunother; 2016 May; 65(5):493-7. PubMed ID: 26970765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering T cells for cancer: our synthetic future.
    Vonderheide RH; June CH
    Immunol Rev; 2014 Jan; 257(1):7-13. PubMed ID: 24329786
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging concepts of T cell metabolism as a target of immunotherapy.
    Chang CH; Pearce EL
    Nat Immunol; 2016 Apr; 17(4):364-8. PubMed ID: 27002844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell metabolic fitness in antitumor immunity.
    Siska PJ; Rathmell JC
    Trends Immunol; 2015 Apr; 36(4):257-64. PubMed ID: 25773310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementing T-cell Function: An Inhibitory Role of the Complement System in T-cell-Mediated Antitumor Immunity.
    Peng W; McKenzie JA; Hwu P
    Cancer Discov; 2016 Sep; 6(9):953-5. PubMed ID: 27587467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.